Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Are pharma giants living up to big promises on development?

In the article, Damiano de Felice and Jayasree K. Iyer write about how pharmaceutical companies are taking action to improve maternal health, and make the case for tracking corporations as well as governments when it comes to meeting global development targets.

Date

22 July 2015

Direct links

Read the full article

The pharmaceutical industry plays a fundamental role in achieving international development targets. This was recognised in the millennium development goals (MDGs), which explicitly mention that providing access to affordable essential drugs in low- and middle-income countries has to be achieved “in cooperation with pharmaceutical companies”. Yet efforts to track progress towards the MDGs have focused mainly on government action rather than corporate contributions.

The Access to Medicine Foundation has stepped into this gap. Since 2008, it has tracked the commitments and actions of pharmaceutical companies to improve access to medicine in low- and middle-income countries. It measures 20 of the world’s largest pharmaceutical companies on their policies and practices for increasing access to medicine.


Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved